Malaysian scientist unveils vegan oyster mushroom burger, offering a healthy, halal-friendly alternative
The innovation, led by Nor Fazila Sulaiman from the Malaysian Agro-Biotechnology Institute's (ABI) Food Biotechnology Department, targets health-conscious consumers and those with dietary restrictions, without compromising on taste or texture.
The idea emerged when Nor Fazila noticed that despite being widely cultivated in Malaysia, grey oyster mushrooms remain underutilised in processed food products.
'This patty is a great substitute for chicken or beef burgers, which typically contain high levels of fat and cholesterol. It's also more affordable and ideal for vegetarians,' she said in an interview with Bernama during the recent World Society for Virology 2025 (WSV2025) international conference in Kuala Lumpur.
More than just a meat substitute, the mushroom burger is rich in dietary fibre and suitable for individuals with allergies to eggs, soy, or meat. It also caters to those following low-fat, gluten-free diets.
The idea emerged when Nor Fazila noticed that despite being widely cultivated in Malaysia, grey oyster mushrooms remain underutilised in processed food products. — Picture via Facebook//Agro-Biotechnology Institute, Malaysia — ABI
Nor Fazila added that the patty contains no eggs, soy, or artificial colouring, making it a fully vegan and halal-friendly option.
However, perfecting the product wasn't without challenges. Due to the high moisture content in mushrooms, frozen patties risk falling apart when thawed. To solve this, she spent a year conducting experiments and stabilised the texture using food-grade ingredients.
'I applied minimal processing methods so small and medium-sized enterprises (SMEs) can adopt the technique without needing costly equipment,' she said.
The prototype is now stable and can be stored frozen for up to three months. Nor Fazila is open to collaborating with companies interested in commercial production.
With its science-backed formulation and responsiveness to local market demands, the mushroom burger represents a significant step towards enhancing food security and making nutritious, inclusive food options more accessible to Malaysians.
ABI is one of three core institutes under the National Institutes of Biotechnology Malaysia (NIBM), operating under the Ministry of Science, Technology and Innovation (MOSTI). — Bernama
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
9 hours ago
- Malay Mail
Drug price transparency kicks in at private clinics and pharmacies, full enforcement by January 2026
KUALA LUMPUR, Aug 3 — The Ministry of Health (MOH) and the Ministry of Domestic Trade and Cost of Living (KPDN) are implementing the drug price display initiative at private health facilities and community pharmacies in stages starting August 1. According to a joint statement by both ministries, the initiative, which was implemented under the Price Control and Anti-Profiteering (Price Marking of Medicines) Order 2025 [P.U.(A) 141/2025] under the Price Control and Anti-Profiteering Act 2011, began on May 1. The statement said the educational enforcement approach was implemented in the first three months ending July 31. 'During the period, 842 facilities consisting of medical clinics, dental clinics and private hospitals as well as community pharmacies were inspected and the majority of them have implemented this initiative with 57 per cent of them complying with the requirements for satisfactory drug price display,' according to the statement. In this regard, enforcement will continue in stages from August 1 through educational approach inspections and advocacy for two months until September 30 and a reminder letter may be issued in the event of non-compliance. According to the statement, starting October 1, compounds would be issued for repeat offences before full enforcement on January 1, 2026. MOH and KPDN also took note of the judicial review action filed in the High Court by seven organisations representing medical and dental practitioners and one private medical practitioner regarding the validity of Order PU (A) 141/2025. 'However, until this statement is issued, there is no court order directing the suspension of the implementation or enforcement of this order. Therefore, Order P.U.(A) 141/2025 remains valid and in force,' according to the statement. MOH and KPDN also expressed their commitment to implement the initiative in an inclusive, phased and prudent manner to ensure that its benefits are enjoyed by consumers and contribute to increasing transparency, accountability and trust in the country's health system. — Bernama
Malay Mail
10 hours ago
- Malay Mail
Jellyfish incident: Competition organiser did not refer to local authorities, says exco
IPOH, Aug 3 — Yesterday's open water swimming competition at Teluk Senangin in Lumut, which saw some 40 participants being stung by jellyfish, was organised without referring to the local authorities. Perak Human Resources, Health, Indian Community Affairs and National Integration Committee chairman A. Sivanesan said the organiser should have at least consulted the Malaysian Maritime Department for information regarding the jellyfish threat in the area. 'The organiser is a private company from outside Perak. We did not know about the event... even the sports and health executive committees did not know about it. 'This is a lesson to outsiders who want to organise any activities… that they must refer to the authorities. Luckily, there were no untoward incidents this time,' he told a media conference after the presentation of Fundus Camera (a specialised instrument used in ophthalmology) for eye checks at Royal Club Ipoh here today. Yesterday, it was reported that at least 40 participants of the Teluk Senangin Open Water Swim 2025 competition were injured after being stung by jellyfish and needed hospital treatment. The organiser also confirmed that the Raja Kecil Besar, Raja Azlan Muzzaffar Shah, who is the son of the Sultan of Perak, Sultan Nazrin Muizzuddin Shah, was one of the participants who competed in the 3-kilometre men's junior 12-19 age group. Meanwhile, Sivanesan said two of the injured participants have been discharged from Manjung Hospital, while those treated as outpatients are in stable conditions. — Bernama
Malay Mail
10 hours ago
- Malay Mail
MOH: Compounds kick in October 1 for private clinics flouting medicine price display rules
KUALA LUMPUR, Aug 3 — The Health Ministry (MOH) will begin issuing compound fines to private healthcare facilities that fail to comply with medicine price display regulations starting October 1. In a statement today, the ministry said the current educational enforcement phase will continue until September 30, involving inspection visits and advocacy sessions. Premises that remain non-compliant may receive reminder notices. 'However, beginning October 1, 2025, compounds may be issued for repeated offences. 'Full enforcement will commence on January 1, 2026,' the ministry said. The price display initiative was rolled out on May 1 at private healthcare facilities and community pharmacies, under the Price Control and Anti-Profiteering (Medicine Price Labelling) Order 2025 [PU(A) 141/2025], issued under the Price Control and Anti-Profiteering Act 2011 [Act 723]. A joint effort with the Domestic Trade and Cost of Living Ministry (KPDN), the move aims to enhance price transparency and protect consumers from profiteering. Over the first three months of implementation, MOH inspected 842 facilities — including medical and dental clinics, private hospitals, and community pharmacies. 'Of these, 57 per cent were found to be in satisfactory compliance with the medicine price display requirement,' the statement said. The MOH and KPDN also clarified that no court order has been issued to delay the enforcement, despite a judicial review filed at the High Court by seven medical associations and a private doctor. 'The PU(A) 141/2025 order remains valid and in effect,' the statement added. The ministry reaffirmed its commitment to implementing the regulation in phases and with care, saying the approach is aimed at ensuring public benefit while strengthening trust in the national healthcare system.
